5395242026-06-23Disclosure45395242026-06-23Disclosure35395242026-06-23Disclosure25395242026-06-23Disclosure15395242026-06-23xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


DR. LAL PATHLABS LIMITED

General information about company

Scrip Code539524
NSE SymbolLALPATHLAB
MSEI SymbolNOTLISTED
Name of the SignatoryVINAY GUJRAL
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceGURUGRAM
Date of Filing23-06-2026
ISIN CodeINE600L01024
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityOtherDr. Lal PathLabs Employee Welfare Trust6409960.38%234611,730.00Sell6386500.38%19-06-202619-06-2026ESOP22-06-2026NATextual Information(1)
2EquityDesignated PersonSatish Kumar Singh5600.00%14747,370.00Buy20340.00%19-06-202619-06-2026ESOP22-06-2026NATextual Information(2)
3EquityDesignated PersonPrashant Kishore45280.00%600990,600.00Sell39280.00%17-06-202617-06-2026Market Sale22-06-2026NSE
4EquityDesignated PersonPrashant Kishore39280.00%8724,360.00Buy48000.00%19-06-202619-06-2026ESOP22-06-2026NATextual Information(3)

Text Block

Textual Information(1)(*) It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share (as the case maybe) under Company’s ESOP plan. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(2)(*)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP Plan. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(3)(*)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP Plan. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).